Evidence map›Paper›PMID 28297790›Full record

ReviewZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2017

[Role of probiotics in treatment of nonalcoholic fatty liver disease].

M Chen, M C Wang, R Ni, J Wang, L Wang, G N Wang, L Y Zhang

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. [Intestinal flora polymorphisms with different lesional stages in an animal model of MAFLD].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2021
    Article
  2. Article
  3. [Association between intestinal flora imbalance and nonalcoholic fatty liver disease].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2017
    Review
  4. [Research advances of relationship between non-alcoholic fatty liver disease and biliary tract diseases].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

M ChenDepartment of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China; Clinical Center of Gastroenterology, Lanzhou University Second Hospital, Lanzhou 730030, China.
M C WangDepartment of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China; Clinical Center of Gastroenterology, Lanzhou University Second Hospital, Lanzhou 730030, China.
R NiDepartment of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China; Clinical Center of Gastroenterology, Lanzhou University Second Hospital, Lanzhou 730030, China.
J WangDepartment of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China.
L WangDepartment of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China; Clinical Center of Gastroenterology, Lanzhou University Second Hospital, Lanzhou 730030, China.
G N WangDepartment of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China; Clinical Center of Gastroenterology, Lanzhou University Second Hospital, Lanzhou 730030, China.
L Y ZhangDepartment of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China; Department of Hepatology, Lanzhou University Second Hospital, Lanzhou 730030, China.
Lanzhou University Second Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases in China and manifests as simple fatty liver, non-alcoholic steatohepatitis, liver cirrhosis, and hepatocellular carcinoma. Studies have shown that intestinal flora can affect the development and progression of NAFLD via the "gut-liver axis" . Probiotics are active microorganisms with beneficial effects on the host, and more and more studies have found that probiotics play a positive role in improving NAFLD. They are cheaper, less harmful, and safer compared with antibiotics and surgery, and therefore, it may become a new method for the prevention and treatment of NAFLD. This article reviews the research advances in probiotics in the treatment of NAFLD, in order to provide a basis for the treatment of NAFLD using probiotics.

Indexed as

ChinaFatty LiverHumansNon-alcoholic Fatty Liver DiseaseProbioticsIntestinal floraNonalcoholic fatty liver diseaseProbiotics

Identifiers

PMID28297790
PMCPMC12768988
OpenAlexW2601121483

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.